Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07570121 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Placental Transfer of Caffeine
A Phase 1 study, sponsored by Indiana University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT07570121 is a Phase 1 study that is actively recruiting participants, run by Indiana University. The registered enrollment target is 30 participants.
The verdict
NCT07570121, a Phase 1 study, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffeine will be given to each pregnant participant before delivery. Blood will be drawn to measure caffeine levels in the pregnant mother. Blood will also be taken from the placenta and from the newborn to measure caffeine levels. This data will be used to form a computer model of the metabolism of caffeine during pregnancy.
Interventions
- DRUG Caffeine citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07570121
The ClinicalTrials.gov registry entry for NCT07570121 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caffeine citrate is the first listed.
NCT07570121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07570121 about?
NCT07570121 is a clinical study titled "Pharmacokinetics and Placental Transfer of Caffeine". The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffeine will be given to each pregnant participant before delivery. Blood will be drawn to measure caffeine levels in the pregnant mother. Blood...
What is the current status of trial NCT07570121?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2026-06-01. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07570121?
The interventions under investigation include: Caffeine citrate (DRUG).
Who is sponsoring clinical trial NCT07570121?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.